Life Expectancy for Severe Pulmonary Hypertension

Severe pulmonary hypertension refers to a condition where the blood pressure in the pulmonary arteries exceeds 70mmHg. For patients who do not seek timely and effective treatment, such as oral medications like Bosentan or Sildenafil, which are commonly used to reduce pulmonary artery pressure, the prognosis can be quite serious. Without proper management, life expectancy for these individuals may typically be less than five years. In fact, the mortality rate associated with untreated severe pulmonary hypertension is often considered higher than that of certain types of cancer.

Impact of Treatment on Survival Rates

However, the outlook significantly improves with appropriate medical intervention. Patients who actively follow prescribed treatment plans—including long-term use of vasodilator medications, regular oxygen therapy, and lifestyle adjustments—can expect a life span of around 10 to 15 years or more. These treatments help reduce pressure in the pulmonary arteries, improve oxygen delivery, and enhance overall heart and lung function.

Importance of Consistent Medication

Consistency in treatment is crucial for individuals with severe pulmonary hypertension. Discontinuing medication or neglecting follow-up care can lead to a rapid decline in health. Adhering strictly to prescribed therapies not only improves quality of life but also significantly increases survival rates. Therefore, medical experts strongly advise patients to maintain regular consultations with their healthcare providers and never stop medication without professional guidance.